(Q44267907)

1 December 2017

Phase 1 trial of combined chemotherapy and reirradiation for recurrent unresectable head and neck cancer (English)

1 reference

1 December 2017

phase I clinical trial

0 references

author name string

Sharon Spencer

1

1 reference

1 December 2017

Richard Wheeler

2

1 reference

1 December 2017

Glenn Peters

3

1 reference

1 December 2017

Ruby Meredith

4

1 reference

1 December 2017

Sam Beenken

5

1 reference

1 December 2017

Lisle Nabel

6

1 reference

1 December 2017

Ann Wooten

7

1 reference

1 December 2017

Seng-Jaw Soong

8

1 reference

1 December 2017

Merle Salter

9

1 reference

1 December 2017

1 February 2003

1 reference

1 December 2017

1 reference

1 December 2017

25

1 reference

1 December 2017

2

1 reference

1 December 2017

118-122

1 reference

Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and reirradiation

1 December 2017

1 reference

7 January 2021

Concomitant chemotherapy and reirradiation as management for recurrent cancer of the head and neck

1 reference

7 January 2021

Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease

1 reference

7 January 2021

Pilot study for the evaluation of simultaneous cisplatin/5-fluorouracil infusion and limited radiation therapy in regionally recurrent head and neck cancer (EST P-C385)

1 reference

7 January 2021

Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients

1 reference

7 January 2021

Reirradiation of recurrent head and neck cancers

1 reference

7 January 2021

Reirradiation of recurrent tumors in the head and neck.

1 reference

7 January 2021

High-dose reirradiation of head and neck cancer with curative intent

1 reference

7 January 2021

Results of twice-a-day irradiation of squamous cell carcinomas of the head and neck

1 reference

7 January 2021

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

1 reference

7 January 2021

Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx

1 reference

7 January 2021

Identifiers

DOI

10.1002/HED.10178

1 reference

1 December 2017

1 reference